As the type 2 immune response has been shown to be closely related to the pathogenesis of UC, OXA-induced colitis is considered a suitable model, and blocking the IL-25 signal of ILC2 may contribute to the remission of oxazolone-induced colitis (8, 10, 21, 22). Here, IL25 is linked to colitis.